can retatrutide be taken nassaly Understanding the starting dose Retatrutide Side Effects Guide: 21

Davies M et al (2021) Semaglutide 24 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial

Research from 2023 found that people lost Two popular GLP-1 medications, Ozempic and Mounjaro (tirzepatide), only have FDA approval for the management of type 2 diabetes

KEY FINDINGS Average weight loss on treatment: 7.9 kg (all GLP-1s) 16.1 kg (newer GLP-1s like semaglutide/tirzepatide) Weight regained after stopping: 0.70.8 kg/month 8.39.6 kg regained in the first year Full return to baseline: 0.9 years (older GLP-1s) 1.7 years (newer GLP-1s) Bottom line: GLP-1s are effective, but without ongoing treatment or structured long-term care, the benefits fade quickly

Samanc B, Samanc Y, Tzn E, et al